These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 89511)
21. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation]. Miyawaki Y; Ueki M; Sugimoto O Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928 [No Abstract] [Full Text] [Related]
23. [Hormone substitution treatment of the menopause]. González-Merlo J; Castelo-Branco C; Celades M Rev Med Univ Navarra; 1992; 37(3):143-51. PubMed ID: 1336213 [No Abstract] [Full Text] [Related]
24. Sex steroids and cancer. Gambrell RD Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519 [TBL] [Abstract][Full Text] [Related]
25. Use of the progestogen challenge test to reduce the risk of endometrial cancer. Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050 [TBL] [Abstract][Full Text] [Related]
29. The prevention of endometrial cancer in postmenopausal women with progestogens. Gambrell RD Maturitas; 1978 Sep; 1(2):107-12. PubMed ID: 755956 [TBL] [Abstract][Full Text] [Related]
30. Severe atypical endometrial changes and sequential contraceptive use. Kaufman RH; Reeves KO; Dougherty CM JAMA; 1976 Aug; 236(8):923-6. PubMed ID: 988889 [TBL] [Abstract][Full Text] [Related]
31. Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adenocarcinoma in mice. Kimura J Cancer Res; 1978 Jan; 38(1):78-82. PubMed ID: 618585 [No Abstract] [Full Text] [Related]
32. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. Speroff L; Rowan J; Symons J; Genant H; Wilborn W JAMA; 1996 Nov; 276(17):1397-403. PubMed ID: 8892714 [TBL] [Abstract][Full Text] [Related]
33. The role of hormones in the etiology and prevention of endometrial cancer. Gambrell RD Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826 [TBL] [Abstract][Full Text] [Related]
34. Review of the status of oestrogen replacement therapy. Bye PG Postgrad Med J; 1978; 54 Suppl 2():7-10. PubMed ID: 368742 [TBL] [Abstract][Full Text] [Related]
35. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Key TJ; Pike MC Br J Cancer; 1988 Feb; 57(2):205-12. PubMed ID: 3358913 [TBL] [Abstract][Full Text] [Related]
36. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia. Gal D; Edman CD; Vellios F; Forney JP Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142 [TBL] [Abstract][Full Text] [Related]
37. Oestrogen replacement and endometrial cancer. A statement by the British Gynaecological Cancer Group. Lancet; 1981 Jun; 1(8234):1359-60. PubMed ID: 6113323 [TBL] [Abstract][Full Text] [Related]
38. Oestrogen therapy and endometrial carcinoma. Studd JW; Thom M; Patterson M Lancet; 1979 Jun; 1(8128):1239. PubMed ID: 87699 [No Abstract] [Full Text] [Related]
39. The effects of cyclical oestrogen therapy and sequential oestrogen/progestogen therapy on the endometrium of postmenopausal women. Whitehead MI; McQueen J; Beard RJ; Minardi J; Campbell S Acta Obstet Gynecol Scand Suppl; 1977; 65():91-101. PubMed ID: 269631 [No Abstract] [Full Text] [Related]
40. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology. Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]